Complete Filing Data
Epsium Enterprise Ltd reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of $8.21 million for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Epsium Enterprise Ltd did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Net Income * | $274.9K | $3.7M | $1.1M |
| Selling And Marketing Expense | $3.1K | $2.4K | $3.0K |
| Revenues | $12.5M | $29.2M | $11.2M |
| Other Nonoperating Income Expense | $1.5K | -$21.3K | $142.4K |
| Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax | $50.8K | $2.9K | -$1.2K |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $50.8K | $2.9K | -$1.2K |
| Operating Income Loss | $407.9K | $4.3M | $1.2M |
| Operating Expenses | $1.2M | $1.2M | $684.3K |
| Nonoperating Income Expense | $1.5K | -$26.5K | $68.1K |
| Net Income Loss Attributable To Noncontrolling Interest | $9.8K | $43.8K | $13.5K |
| Income Tax Expense Benefit | $124.7K | $588.0K | $175.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $409.4K | $4.3M | $1.3M |
| Gross Profit | $1.6M | $5.5M | $1.9M |
| General And Administrative Expense | $1.2M | $1.2M | $681.2K |
| Cost Of Goods And Services Sold | $10.9M | $23.7M | $9.3M |
| Comprehensive Income Net Of Tax | $325.7K | $3.7M | $1.1M |
| Interest Expense Nonoperating | $5.3K | $74.2K | |
| Imputed Interest Expense | $5.0K | $70.7K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Stockholders Equity * | $8.1M | $7.8M | $4.1M | $2.9M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $148.8K | $1.3M | $525.6K | $272.0K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$1.2M | $790.6K | $253.5K | |
| Adjustments For Decrease Increase In Tax Payable | $124.7K | $565.2K | $175.0K | |
| Repayments Of Related Party Debt | $276.1K | $5.0M | $1.0M | |
| Property Plant And Equipment Net | $78.1K | $10.0K | $29.2K | |
| Operating Lease Right Of Use Asset | $158.1K | $243.4K | $255.7K | |
| Operating Lease Liability Noncurrent | $79.8K | $158.8K | $187.9K | |
| Operating Lease Liability Current | $85.9K | $100.2K | $76.1K | |
| Taxes Payable Current | $1.3M | $1.2M | ||
| Retained Earnings Accumulated Deficit | $7.7M | $7.5M | ||
| Other Receivables | $19.2K | $17.6K | ||
| Liabilities Noncurrent | $79.8K | $158.8K | ||
| Liabilities Current | $2.3M | $2.7M | ||
| Liabilities And Stockholders Equity | $10.6M | $10.8M | ||
| Liabilities | $2.4M | $2.9M | ||
| Inventory Net | $4.6M | $5.4M | ||
| Employee Related Liabilities Current | $53.7K | $51.1K | ||
| Common Stock Value | $240.00 | $240.00 | ||
| Assets Noncurrent | $236.2K | $253.4K | ||
| Assets Current | $10.4M | $10.5M | ||
| Assets | $10.6M | $10.8M | ||
| Advances On Inventory Purchases | $4.4M | $3.1M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $44.8K | -$6.0K | ||
| Accounts Receivable Net Current | $1.2M | $685.7K | ||
| Accounts Payable Current | $538.9K | $1.4M | ||
| Repayments Of Bank Debt | $26.8K | $104.5K | ||
| Minority Interest | $94.2K | $84.4K | ||
| Deposits Assets Current | $45.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Payments To Acquire Property Plant And Equipment | $83.2K | $770.00 | $4.2K |
| Net Cash Provided By Used In Operating Activities | -$1.4M | $1.9M | $1.4M |
| Net Cash Provided By Used In Investing Activities | -$128.0K | -$770.00 | -$11.7K |
| Increase Decrease In Prepaid Expense | $1.3M | $3.0M | -$292.2K |
| Increase Decrease In Other Receivables | $1.5K | -$11.2K | -$613.00 |
| Increase Decrease In Operating Lease Liability | -$94.4K | -$4.9K | -$31.0K |
| Increase Decrease In Inventories | -$805.1K | -$435.8K | $1.1M |
| Increase Decrease In Employee Related Liabilities | $2.2K | $50.2K | -$333.00 |
| Increase Decrease In Accounts Receivable | $478.0K | $437.4K | -$68.0K |
| Increase Decrease In Accounts Payable Trade | -$861.2K | $546.7K | $705.4K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $614.00 | -$32.00 | $409.00 |
| Net Cash Provided By Used In Financing Activities | $352.9K | -$1.1M | -$1.1M |
| Proceeds From Related Party Debt | $629.0K | $4.0M | |
| Increase Decrease In Other Accounts Payable | -$12.5K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $80.00 | |
| Weighted Average Number Of Shares Outstanding Basic | 12.0M | 12.0M | 12.0M | |
| Weighted Average Number Of Diluted Shares Outstanding | 12.0M | 12.0M | 12.0M | |
| Preferred Stock Shares Authorized | 200.0M | 200.0M | 200.0M | |
| Earnings Per Share Diluted | $0.02 | $0.31 | $0.09 | |
| Earnings Per Share Basic | $0.02 | $0.31 | $0.09 | |
| Common Stock Shares Outstanding | 12.0M | 12.0M | ||
| Common Stock Shares Authorized | 800.0M | 800.0M | 800.0M | |
| Common Stock Shares Issued | 12.0M | 12.0M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Depreciation And Amortization | $15.4K | $20.0K | $22.6K |
| Reserve Capital | $1.6K | $1.6K | |
| Prepaid Expense Current | $3.8K | $3.4K | |
| Additional Paid In Capital | $328.2K | $328.2K | |
| Other Noncash Expense | $86.5K | $12.1K | $17.8K |
Most recent annual filing with the SEC: April 30, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.